Latest News

Features

Multinational trial of low-cost drug targets primary inflammation in PAD patients

As the global burden of peripheral arterial disease (PAD) continues to rise, so too does the need for strategies to reduce an “unacceptably high”...

Why the ESVS focused update on claudication recommends selective use of...

In response to Peter Schneider (San Francisco, USA), Thomas Zeller (Bad Krozingen, Germany) and colleagues' recent comment article for Vascular News on the European...

Videos

In part two of a Charing Cross (CX) Symposium special roundtable discussion on the use of drug-based technology use in the lower extremity, Peter...

Most read

Features

Profiles

Anahita Dua

Kak Khee Yeung

Marianne Brodmann